Interventions for Tuberculosis Control and Elimination 2002

1141. Ashtekar DR, Costa-Perira R, Nagrajan K, Vishvanathan N, Bhatt AD, Rittel
W. In vitro and in vivo activities of the nitroimidazole CGI 17341 against
Mycobacterium tuberculosis. Antimicrob Agents Chemother 1993; 37: 183-6.
1142. Berlin OGW, Young LS, Floyd-Reising SA, Bruckner DA. Comparative in
vitro activity of the new macrolide A-56268 against mycobacteria. Eur J Clin
Microbiol 1987; 6: 486-7.
1143. Heifets LB, Lindholm-Levy PJ, Comstock RD. Clarithromycin minimal
inhibitory and bactericidal concentrations against Mycobacterium avium. Am
Rev Respir Dis 1992; 145: 856-8.
1144. Luna-Herrera J, Reddy VM, Daneluzzi D, Gangadharam PRJ. Antituberculosis
activity of clarithromycin. Antimicrob Agents Chemother 1995; 39: 2692-5.
1145. Mor N, Esfandiari A. Synergistic activities of clarithromycin and pyrazinamide
against Mycobacterium tuberculosis in human macrophages. Antimicrob Agents
Chemother 1997; 41: 2035-6.
1146. Brown BA, Wallace RJ, Onyl GO, De Rosas V. Activities of four macrolides,
including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae,
and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;
36: 180-4.
1147. Burman WJ, Reves RR, Rietmeijer CA, Cohn DL. A retrospective comparison
of clarithromycin versus rifampin in combination treatment for disseminated
Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion
requirements. Int J Tuberc Lung Dis 1997; 1: 163-9.
1148. Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M,
Wormser G, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G,
Craft JC. A randomized trial of clarithromycin as prophylaxis against disseminated
Mycobacterium avium complex infection in patients with advanced
acquired immunodeficiency syndrome. N Engl J Med 1996; 335: 384-91.
1149. Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW,
Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. A comparison
of two regimens for the treatment of Mycobacterium avium complex bacteremia
in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol,
clofazimine, and ciprofloxacin. N Engl J Med 1996; 335: 377-83.
1150. Dautzenberg B, Truffot-Pernot C, Hazebroucq J, Legris S, Guérin C, Begelman C,
Guermonprez G, Fievet MH, Chastang C, Grosset J. A randomized comparison
of two clarithromycin doses for treatment of Mycobacterium avium complex
infections. Infection 1997; 25: 16-21.
1151. Dubé MP, Sattler FR, Torriani FJ, See D, Havlir DV, Kemper CA, Dezfuli MG,
Bozzette SA, Bartok AE, Leedom JM, Tilles JG, McCutchan JA. A randomized
evaluation of ethambutol for prevention of relapse and drug resistance during
treatment of Mycobacterium avium complex bacteremia with clarithromycinbased
combination therapy. J Infect Dis 1997; 176: 1225-32.
246